10829350|t|Rivastigmine for Alzheimer's disease.
10829350|a|Rivastigmine (Exelon-Novartis) is the second cholinesterase inhibitor marketed for symptomatic treatment of mild to moderately severe Alzheimer's dementia, and follows [symbol: see text] donepezil (Aricept-Eisai; Pfizer). Previously, we have been "unconvinced of the value of donepezil in routine clinical practice". Rivastigmine has been promoted with the slogan "Beyond cognition: improving functional ability". Does rivastigmine offer useful benefits in Alzheimer's disease?
10829350	0	12	Rivastigmine	Chemical	MESH:D000068836
10829350	17	36	Alzheimer's disease	Disease	MESH:D000544
10829350	38	50	Rivastigmine	Chemical	MESH:D000068836
10829350	83	97	cholinesterase	Gene	590
10829350	172	192	Alzheimer's dementia	Disease	MESH:D000544
10829350	225	234	donepezil	Chemical	MESH:D000077265
10829350	236	249	Aricept-Eisai	Chemical	-
10829350	314	323	donepezil	Chemical	MESH:D000077265
10829350	355	367	Rivastigmine	Chemical	MESH:D000068836
10829350	457	469	rivastigmine	Chemical	MESH:D000068836
10829350	495	514	Alzheimer's disease	Disease	MESH:D000544
10829350	Negative_Correlation	MESH:D000077265	MESH:D000544
10829350	Negative_Correlation	MESH:D000068836	MESH:D000544
10829350	Negative_Correlation	MESH:D000068836	590

